SCHEMBL8914459

SCHEMBL8914459

CCCN(C(=O)OC)C1Cc2ccc(C3=NNC(=O)CC3)cc2C1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 9/20 0.45
PDE3A Q14432 9/20 0.45
PDE4B Q07343 7/20 0.45
PDE4A P27815 6/20 0.45
PDE4C Q08493 6/20 0.45
PDE4D Q08499 6/20 0.45
MAPT P10636 2/20 0.43
LMNA P02545 1/20 0.43
NPY1R P25929 1/20 0.43
NPY2R P49146 1/20 0.43
KMT2A Q03164 2/20 0.37
DRD2 P14416 1/20 0.37
DRD3 P35462 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
KCNH2 Q12809 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8912378 0.88 MAPT (0.40) PDE3BPDE3APDE4BPDE4APDE4C
SCHEMBL8912302 0.87 MAPT (0.42) PDE3BPDE3APDE4BPDE4APDE4C
SCHEMBL8911969 0.86 PDE3B (0.40) PDE3BPDE3APDE4BPDE4APDE4C
SCHEMBL8303551 0.76 LMNA (0.48) PDE3BPDE3APDE4BPDE4APDE4C
SCHEMBL8911889 0.76 CA12 (0.51) PDE3BPDE3APDE4BPDE4APDE4C
SCHEMBL8912023 0.75 CA12 (0.49) PDE3BPDE3APDE4BPDE4APDE4C
SCHEMBL8300078 0.75 MAPT (0.46) PDE3BPDE3APDE4BPDE4APDE4C
SCHEMBL8911986 0.74 MAPT (0.42) PDE3BPDE3APDE4BPDE4APDE4C
SCHEMBL8911629 0.74 MAPT (0.42) PDE3BPDE3APDE4BPDE4APDE4C
SCHEMBL8302599 0.73 PDE3B (0.46) PDE3BPDE3APDE4BPDE4APDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5605901-A THERAPY FOR GRAM-NEGATIVE BACTERIA, NEPHRITIS TANABE SEIYAKU CO., LTD. (JP) 1997-02-25 US disclosed
US-5543409-A Indane derivatives for treating endotoxin shock and/or nephritis TANABE SEIYAKU CO., LTD. (JP) 1996-08-06 US disclosed
EP-0661274-A1 Indane derivatives, processes for preparing the same and synthetic intermediate of the same TANABE SEIYAKU CO., LTD. (JP) 1995-07-05 EP disclosed